Essentials Masterclass: Antibiotics – Why Shorter is Better, part 1

Antibiotic duration is often longer than the evidence supports, and excess exposure mainly selects resistance in colonizing flora rather than the target pathogen. Across common outpatient infections, the best strategy is the narrowest effective agent for the shortest effective course.

Shorter Narrower Antibiotic Strategy

• Resistance ecology principle: Antibiotic resistance is driven largely by selection pressure on colonizing bacteria like gut flora, so unnecessarily broad or prolonged courses can do harm even when the infection improves.
• Arbitrary duration problem: Seven-, ten-, and fourteen-day prescriptions are often habit rather than science; across many common infections, shorter courses are usually just as effective.
• Targeted spectrum choice: The core stewardship move is matching therapy to the likely pathogen set and avoiding collateral damage, with nitrofurantoin a useful example of minimal gut-flora disruption.
• Symptom-guided stopping point: Once symptoms are clearly improving, ongoing benefit from continuing the same antibiotic often falls off quickly. We get into the practical stopping nuance in the episode.

Respiratory Infections and Sinusitis

• Outpatient CAP first line: IDSA outpatient pneumonia guidance favors narrow oral therapy with amoxicillin 1 g three times daily or doxycycline 100 mg twice daily, each for at least 5 days.
• Borderline pneumonia caution: Subtle chest radiograph changes do not always mandate antibiotics; in low-certainty cases, watchful waiting with solid return precautions can be appropriate, especially outside higher-risk groups.
• Acute bronchitis distinction: Uncomplicated acute bronchitis does not improve with antibiotics, and patients should be told the cough can last about 3 weeks without implying treatment failure.
• Chronic bronchitis exacerbation: Antibiotics can help acute exacerbations of chronic bronchitis or COPD marked by increased dyspnea, sputum volume, and sputum purulence, with amoxicillin-clavulanate a practical choice.
• Bacterial sinusitis timing: Worsening sinus symptoms beyond day 10 points toward bacterial sinusitis, and short-course therapy performs well. We walk through the agent choice nuance in the chapter.

Urinary and Skin Infection Pearls

• Pyelonephritis drug logic: Fluoroquinolones are strong oral options for younger women with pyelonephritis because they achieve high renal tissue and urinary levels, allowing short effective courses.
• Nitrofurantoin sweet spot: Nitrofurantoin 100 mg twice daily for 5 days is a high-value option for uncomplicated cystitis in women when renal function is adequate, with limited impact on gut flora.
• Male UTI caveat: Afebrile UTI in men can often be treated with 7 days of ciprofloxacin or TMP-SMX, but missing prostatitis will lead you into the wrong duration strategy.
• Cellulitis coverage myth: For uncomplicated cellulitis, cephalexin alone performs as well as cephalexin plus TMP-SMX, arguing against reflex MRSA double coverage in routine cases.
• Drained abscess benefit: After incision and drainage of an uncomplicated abscess, TMP-SMX for 7 days improves cure compared with placebo, though shorter courses may still be enough in selected patients.

References:

• Link to Brad Spellberg MD website, Shorter Is Better 
• Murray BE, et al. Emergence of high-level trimethoprim resistance in fecal Escherichia coli during oral administration of trimethoprim or trimethoprim--sulfamethoxazole. N Engl J Med. 1982;306(3):130-135. PMID: 7033781
• Lee RA, et al. Appropriate Use of Short-Course Antibiotics in Common Infections: Best Practice Advice From the American College of Physicians. Ann Intern Med. 2021;174(6):822-827. PMID: 33819054
• Williams DJ, et al. Short- vs Standard-Course Outpatient Antibiotic Therapy for Community-Acquired Pneumonia in Children: The SCOUT-CAP Randomized Clinical Trial. JAMA Pediatr. 2022;176(3):253-261. PMID: 35040920
• Uranga A, et al. Duration of Antibiotic Treatment in Community-Acquired Pneumonia: A Multicenter Randomized Clinical Trial. JAMA Intern Med. 2016;176(9):1257-1265. PMID: 27455166
• Metlay JP, et al. Diagnosis and Treatment of Adults with Community-acquired Pneumonia. An Official Clinical Practice Guideline of the American Thoracic Society and Infectious Diseases Society of America. Am J Respir Crit Care Med. 2019;200(7):e45-e67. PMID: 31573350
• El Moussaoui R, et al. Short-course antibiotic treatment in acute exacerbations of chronic bronchitis and COPD: a meta-analysis of double-blind studies. Thorax. 2008;63(5):415-422. PMID: 18234905
• Williams JW Jr, et al. Randomized controlled trial of 3 vs 10 days of trimethoprim/sulfamethoxazole for acute maxillary sinusitis. JAMA. 1995;273(13):1015-1021.PMID: 7897784
• Henry DC, et al. Randomized double-blind study comparing 3- and 6-day regimens of azithromycin with a 10-day amoxicillin-clavulanate regimen for treatment of acute bacterial sinusitis. Antimicrob Agents Chemother. 2003;47(9):2770-2774. PMID: 12936972
• Talan DA, et al. Trimethoprim-Sulfamethoxazole versus Placebo for Uncomplicated Skin Abscess. N Engl J Med. 2016;374(9):823-832. PMID: 26962903